RETT SYNDROME WITH PROVEN MECP2 MUTATION
Clinical trials for RETT SYNDROME WITH PROVEN MECP2 MUTATION explained in plain language.
Never miss a new study
Get alerted when new RETT SYNDROME WITH PROVEN MECP2 MUTATION trials appear
Sign up with your email to follow new studies for RETT SYNDROME WITH PROVEN MECP2 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common antidepressant ease rett syndrome?
Disease control Recruiting nowThis phase II trial is testing whether mirtazapine, an antidepressant, can improve mood, sleep, and motor symptoms in people with Rett syndrome. The study will enroll 54 females aged 5 to 40 with a confirmed MECP2 mutation. Participants will receive increasing doses of mirtazapin…
Matched conditions: RETT SYNDROME WITH PROVEN MECP2 MUTATION
Phase: PHASE2 • Sponsor: University of Trieste • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Intensive brain training shows promise for kids with developmental delays
Knowledge-focused Recruiting nowThis study looks at how a 2-week, personalized therapy program helps children aged 4-12 with conditions like cerebral palsy, autism, or genetic disorders. Kids get about 2.5 hours of tailored therapy each day, focusing on skills like movement, attention, and communication. The go…
Matched conditions: RETT SYNDROME WITH PROVEN MECP2 MUTATION
Sponsor: Healing Hope International • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC